CS
FBIO icon

Credit Suisse’s Fortress Biotech FBIO Stock Holding History

Credit Suisse’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,244
Closed -$59K – 4372
2020
Q4 		$59K Buy
+1,244
New +$53.9K ﹤0.01% 4239
2020
Q2 		– Sell
-11,278
Closed -$320K – 4015
2020
Q1 		$320K Buy
11,278
+3,751
+50% +$125K ﹤0.01% 3393
2019
Q4 		$290K Buy
+7,527
New +$193K ﹤0.01% 3839
2018
Q2 		– Sell
-1,077
Closed -$74K – 4018
2018
Q1 		$74K Buy
+1,077
New +$68.2K ﹤0.01% 3846
2017
Q4 		– Sell
-1,501
Closed -$99K – 4050
2017
Q3 		$99K Buy
+1,501
New +$101K ﹤0.01% 4092
2017
Q1 		– Sell
-921
Closed -$38K – 3883
2016
Q4 		$38K Buy
921
+3
+0.3% +$112 ﹤0.01% 4039
2016
Q3 		$41K Sell
918
-573
-38% -$24.4K ﹤0.01% 4035
2016
Q2 		$60K Buy
+1,491
New +$69.4K ﹤0.01% 4132
2014
Q3 		– Sell
-3,947
Closed -$102K – 4489
2014
Q2 		$102K Buy
3,947
+1,840
+87% +$48.5K ﹤0.01% 4532
2014
Q1 		$62K Buy
2,107
+547
+35% +$21.3K ﹤0.01% 4563
2013
Q4 		$61K Sell
1,560
-5,871
-79% -$227K ﹤0.01% 4515
2013
Q3 		$781K Buy
7,431
+6,175
+492% +$757K ﹤0.01% 3156
2013
Q2 		$162K Buy
+1,256
New +$185K ﹤0.01% 3911

Other funds holding FBIO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SAM
Shikiar Asset Management New York $347M AUM 23.44% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
CL
CPWM LLC Seattle, Washington $1.06B AUM 14.49% 1-Year Est. Return

Credit Suisse's FBIO Position: Q1 2021 in Review

Credit Suisse sold out of Fortress Biotech (FBIO) in Q1 2021, closing a stake of 1,244 shares — an estimated $59K sold.

Credit Suisse first reported a position in FBIO in Q2 2013 and held it in 13 quarters. The position peaked at $781K in Q3 2013. 85 funds tracked by Wall St. Rank hold FBIO as of Q1 2021.

  • Credit Suisse reported no remaining Fortress Biotech position as of Q1 2021 after selling out during the quarter.
  • Credit Suisse sold 1,244 Fortress Biotech shares in Q1 2021, an estimated $59K.
  • Credit Suisse first reported a position in Fortress Biotech in Q2 2013 and held it in 13 quarters.
  • Credit Suisse's Fortress Biotech position peaked at $781K in Q3 2013.
  • 85 funds tracked by Wall St. Rank held Fortress Biotech as of Q1 2021.

Based on Credit Suisse's 13F filing for Q1 2021, filed 14 May 2021.